Kristen R. Scarpato, MD, MPH, discusses what level of evidence is necessary to shift the standard of care in BCG-naive NMIBC.
Kristen R. Scarpato, MD, MPH
Advertisement
Articles by Kristen R. Scarpato, MD, MPH
Benefits include improved quality of life and symptom management.
Advances allow for more accurate detection of metastatic disease.
Renal mass biopsy should be used for patients in whom results would impact management decisions.
Advertisement
Latest Updated Articles
Update on advanced imaging in prostate cancerPublished: June 11th 2021 | Updated:
The small renal mass and in-office biopsy: An overviewPublished: September 17th 2020 | Updated:
Considerations for palliative care in urologic oncologyPublished: November 25th 2021 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
Interpreting PSMA PET Imaging in Prostate Cancer
5